Opendata, web and dolomites


Launching the First Non-Invasive Point of Care Diagnostic Test for Traumatic Brain Injury

Total Cost €


EC-Contrib. €






 Medicortex project word cloud

Explore the words cloud of the Medicortex project. It provides you a very rough idea of what is the project "Medicortex" about.

spinal    aring    biomarker    exceed    distributors    always    central    margin    diagnostic    traumatic    glycan    biotech    unfortunately    tbi    patents    lasse    risks    tests    difficult    protected    track    diagnose    annually    accurate    poc    injuries    putting    medicortex    medical    kvist    providers    biomarkers    mri    urine    scans    mild    ed    injury    ct    envision    anxiety    50    record    care    billion    nervous    market    suggested    harel    samples    director    innovative    charge    single    efficient    brain    founder    25x    sell    quick    rten    correlated    innovation    scan    accurately    irritability    reduce    pharmaceutical    sufficient    cord    standard    patient    approved    correctly    confirmed    cognitive    active    moderate    limaa    dr    auml       industry    point    untreated    charged    bioanalytical    dizziness    500    tools    head    90    none    diagnostics    identification    price    instead    proven    healthcare    depression    evaluations    headache    saliva    kit    academia    letter    25    impairment   

Project "Medicortex" data sheet

The following table provides information about the project.


Organization address
city: TURKU
postcode: 20520
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-11-01   to  2019-02-28


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MEDICORTEX FINLAND OY FI (TURKU) coordinator 50˙000.00


 Project objective

Traumatic Brain Injury (TBI) is the leading cause of central nervous system impairment, over traumatic spinal cord injury. Mild and moderate TBI cases represent more than 90% of TBI injuries but are unfortunately the most difficult to accurately diagnose. Currently, standard TBI diagnostic tools are based on CT scans, MRI scans or cognitive evaluations which are not always sufficient accurate to correctly diagnose mild and moderate cases, putting the patient at risks (long-term consequences of untreated TBI include headache, dizziness, irritability, anxiety and depression). Medicortex is an innovative point of care test based on novel glycan-based biomarkers. The Medicortex diagnostic kit is a cost-efficient, quick and reliable test based on specific biomarkers for the identification of TBI in both saliva and urine samples. We have protected the innovation with several patents. Many biomarkers have been suggested for TBI but none has resulted in an approved test. We have already proven that our biomarker is strongly correlated with TBI, allowing us to address a TBI point of care (POC) diagnostics market that will exceed €2 billion annually. We will sell the Medicortex TBI tests and envision a price to distributors of €25. We expect distributors to charge €50 to healthcare providers and make a margin of 50%. This will reduce the TBI diagnostics cost by a factor of 10-25x for healthcare systems as a single test can be charged to the patient for less than €100 instead of €1,000 for a CT scan or €2,500 for an MRI scan. Two distributors have confirmed they interest in a letter. Our Founder Dr. Harel has many years of experience in the pharmaceutical and biotech industry. Our Medical Director Dr. Mårten Kvist is active in academia and our Head of R&D Dr. Lasse Välimaa has a track record in R&D of bioanalytical methods and medical diagnostics.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MEDICORTEX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MEDICORTEX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

HAC (2019)


Read More  

SA-VOIR (2019)

Assessing the feasibility of MT-011, a first-in-class drug to treat glaucoma and other neurodegenerative diseases via a breakthrough mechanism-of-action

Read More  

Totem Spoon (2019)

Interactive Digital Signage with emotional intelligence for smart cities

Read More